Back

The BNP genetic variant rs198389: cardiovascular phenotype and risk in stage A/B heart failure subjects from the STOP-HF Trial

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Valentina Cannone

University of Parma, Parma (Italy)

9 More presentations in this session

Presentation thumbnail
Cytokines, Epicardial Adipose Tissue and Diastolic Function in the General Population
Associate Professor R. Hullin (Lausanne, CH)
Abstract
Presentation thumbnail
Neurohormonal function across categories of systolic dysfunction in chronic heart failure
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
BNP in patients with severe aortic valve stenosis undergoing valve replacement: pathophysiological determinants and long-term impact on mortality
Doctor L. Weber (CH)
Abstract Slides Video
Presentation thumbnail
Elevated suppression of tumorigenicity 2 associated with poor outcome in heart failure with preserved ejection fraction
Doctor C. Roy (La Louviere, BE)
Abstract Slides Video
Presentation thumbnail
HF-DACH 2018, Cardiac fibrosis marker GDF-15 is associated with prognosis in treatment naive cancer patients
Doctor H. Arfsten (Vienna, AT)
Abstract

Access the full session

Session thumbnail
Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources